Evidence map›Paper›PMID 42034643›Full record

ArticleNPJ systems biology and applications2026

The complexome contextualizes proteomics data to fingerprint biological states and highlight perturbed functional modules in disease.

Mainak Guharoy, Isabelle Adant, Matthew Bird, Alexander Botzki, James Collier, Jonas Dehairs, Stefaan Derveaux, Simon Devos, Geert Goeminne, Francis Impens and 13 more

Abstract read
In one paragraph

Article in NPJ systems biology and applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Mainak GuharoyMetabolomics Core Facility Leuven, VIB Technologies, VIB, Leuven, Belgium. mainak.guharoy@vib.be.ORCID http://orcid.org/0000-0003-1354-2872
Isabelle AdantMetabolomics Core Facility Leuven, VIB Technologies, VIB, Leuven, Belgium.
Matthew BirdMetabolomics Core Facility Leuven, VIB Technologies, VIB, Leuven, Belgium.
Alexander BotzkiVIB Technologies, VIB, Ghent, Belgium.
James CollierMetabolomics Core Facility Leuven, VIB Technologies, VIB, Leuven, Belgium.
Jonas DehairsLaboratory of Lipid Metabolism and Cancer, Leuven Cancer Institute, Department of Oncology, KU Leuven, Leuven, Belgium.
Stefaan DerveauxNucleomics Core Facility, VIB Technologies, VIB, Leuven, Belgium.
Simon DevosProteomics Core Facility, VIB Technologies, VIB, Ghent, Belgium.
Geert GoeminneMetabolomics Core Facility Ghent, VIB Technologies, VIB, Ghent, Belgium.
Francis ImpensProteomics Core Facility, VIB Technologies, VIB, Ghent, Belgium.
Andrea Jáñez PedrayesMetabolomics Core Facility Leuven, VIB Technologies, VIB, Leuven, Belgium.
Rekin's JankyNucleomics Core Facility, VIB Technologies, VIB, Leuven, Belgium.
Ruth MaesNucleomics Core Facility, VIB Technologies, VIB, Leuven, Belgium.
Pedro MagalhãesLaboratory of Applied Mass Spectrometry, Department Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Teresa M MaiaProteomics Core Facility, VIB Technologies, VIB, Ghent, Belgium.
Wouter MeerssemanCenter of Metabolic Diseases, University Hospitals Leuven, Leuven, Belgium.
Daisy RymenMetabolic Centre, University Hospitals Leuven, Leuven, Belgium.
Johannes V SwinnenLaboratory of Lipid Metabolism and Cancer, Leuven Cancer Institute, Department of Oncology, KU Leuven, Leuven, Belgium.
Delphi Van HaverProteomics Core Facility, VIB Technologies, VIB, Ghent, Belgium.
Dries VerdegemMetabolomics Core Facility Leuven, VIB Technologies, VIB, Leuven, Belgium.
Peter WittersMetabolic Centre, University Hospitals Leuven, Leuven, Belgium.
David CassimanLaboratory of Hepatology, Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, Leuven, Belgium.
Bart GhesquiereMetabolomics Core Facility Leuven, VIB Technologies, VIB, Leuven, Belgium. bart.ghesquiere@kuleuven.be.

Funding

Fonds Wetenschappelijk Onderzoek-Vlaanderen 18B4322NKU Leuven EFF-D2860-C14/17/110
6 · The paper itself

Abstract

Analyzing single omics and integrating multimodal omics datasets to capture functional dysregulation in disease remains challenging. Here, we propose a bioinformatics framework that leverages curated datasets of protein complexes ('complexome') as a foundation for proteomics data integration. Available for human and other model organisms, the complexome provides a global view of cellular function, enabling queries with proteomics datasets. We first benchmarked how protein abundances across human tissues shape distinct complexomic profiles, serving to fingerprint biological activity. Next, we analyzed complexome remodeling using disease versus control proteomics quantifications. Using proteomics data from fibroblasts of patients with genetically confirmed metabolic defects, we identified significant perturbations in mitochondrial oxidative phosphorylation complexes and additional complexes involved in wider mitochondrial functions. The complexome provides a systems-wide approach to dissect mechanisms underlying disease-related functional and phenotypic changes by mapping measured protein-level perturbations to specific molecular complexes. The software is available as a Python notebook at https://github.com/mguharoy/Complexome .

Indexed as

Computational BiologyProteomicsHumansMitochondriaMultiomicsOxidative PhosphorylationProteomeSoftwareProteome

Identifiers

PMID42034643
PMCPMC13462548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.